How long should telomeres be?

Current Hypertension Reports

Volumn 3, Issue 2, 2001, Pages 145-151

  Aviv, Abraham ^a   Harley, Calvin B ^b  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b GERON CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; ANIMAL; CARDIOVASCULAR DISEASE; GENETICS; HUMAN; MOUSE; PATHOLOGY; REVIEW; TELOMERE;

AGING; ANIMALS; CARDIOVASCULAR DISEASES; HUMANS; MICE; TELOMERE;

EID: 0035315847     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-001-0029-3     Document Type: Article

References (99)

1. Kirkwood TB, Austad SN: Why do we age? Nature 2000, 408: 233-238.
2. Finkel T, Holbrook NJ: Oxidants, oxidative stress and the biology of aging. Nature 2000, 408: 239-247.
3. DePinho RA: The age of cancer. Nature 2000, 408: 248-254.
4. Guarente L, Kenyon C: Genetic pathways that regulate aging in model organisms. Nature 2000, 408: 255-262.
5. Martin GM, Oshima J: Lessons from human progeroid syndromes. Nature 2000, 408: 263-266.
6. Hayflick L: The future of ageing. Nature 2000, 408: 267-269.
7. Medwar PB: An Unsolved Problem in Biology. The Uniqueness of the Individual. New York: Dover; 1952.
8. Williams GC: Pleitrophy, natural selection and the evolution of senescence. Evolutions 1957, 11: 398-411.
9. Jazwinski SM: Longevity, genes and aging. Science 1996, 273: 54-59.
10. Finch CE, Kirkwood TBL: Chance, Development and Aging. New York, Oxford: Oxford Univesity Press; 2000.
11. Kirkwood TB, Holliday R: The evolution of ageing and longevity. Proc R Soc Lond B Biol Sci 1979, 205: 531-546.
12. Kirkwood TB, Rose MR: Evolution of senescence: late survival sacrificed for reproduction. Philos Trans R Soc Lond B Biol Sci 1991, 332: 15-24.
13. Holliday R: The evolution of human longevity. Perspect Biol Med 1996, 40: 100-107.
14. Blackburn EH: Structure and function of telomeres. Nature 1991, 350: 569-573.
15. Olovnikov AM: A theory of marginotomy: the incomplete copying of template margin in enzymic synthesis of pronucleotides and biological significance of the phenomenon. J Theor Biol 1973, 41: 181-190.
16. Watson JD: Origin of concatemeric T7 DNA. Nature New Biol 1972, 239: 197-201.
17. Levy MZ, Allsopp RC, Futcher AB, et al.: Telomere end-replication problem and cell aging. J Mol Biol 1992, 225: 951-960.
18. Greider CW, Blackburn EH: Identification of a specific telomere terminal transferase enzyme with two kinds of primer specificity. Cell 1985, 51: 405-413.
19. Morin GB: The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 1989, 59: 521-529.
20. Nakamura TM, Morin GB, Chapman KB, et al.: Telomerase catalytic subunit homologs from fission yeast and human. Science 1997, 277: 955-959.
21. Feng J, Funk WD, Wang S-S, et al.: The RNA component of human telomerase. Science 1995, 269: 1236-1241.
22. Allsopp RC, Vaziri H, Patterson C, et al.: Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci U S A 1992, 89: 10114-10118.
23. Chang E, Harley CB: Telomere length and replicative aging in human vascular tissues. Proc Natl Acad Sci U S A 1995, 92: 11190-11194.
24. Effros RB, Allsopp R, Chiu C-P, et al.: Shortened telomeres in the expanded CD28-CD8+T cell subset in HIV disease implicate replicative senescence in HIV pathogenesis. AIDS 1996, 10:F17-F22. (Pubitemid 26229506)
25. Harley CB, Vaziri H, Counter CM, et al.: The telomere hypothesis of cellular aging. Exp Gerontol 1992, 27: 375-382.
26. Hastie ND, Dempster M, Dunlop MG, et al.: Telomere reduction in human colorectal carcinoma and with ageing. Nature 1990, 346: 866-868.
27. Kojima H, Yokosuka O, Imazeki F, et al.: Telomerase activity and telomere length in hepatocellular carcinoma and chronic liver disease. Gastroenterology 1997, 112: 493-500.
28. Lindsey J, McGill NI, Lindsey LA, et al.: In vivo loss of telomeric repeats with age in humans. Mutat Res 1991, 256: 45-48.
29. Urabe Y, Nouso K, Higashi T, et al.: Telomere length in human liver diseases. Liver 1996, 16: 293-297.
30. Vaziri H, Schachter F, Uchida I, et al.: Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am J Hum Genet 1993, 52: 661-667.
31. Weng N-P, Palmer LD, Levine BL, et al.: Tales of tails: regulation of telomere length and telomerase activity during lymphocyte development, differentiation, activation, and aging. Immunol Rev 1997, 160: 43-54.
32. Counter CM, Avilion AA, LeFeuvre CE, et al.: Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 1992, 11: 1921-1929.
33. Kim NW, Piatyszek MA, Prowse KR, et al.: Specific association of human telomerase activity with immortal cells and cancer. Science 1994, 266: 2011-2014.
34. Shay JW, Bacchetti S: A survey of telomerase activity in human cancer. Eur J Cancer 1997, 33: 777-791.
35. Wright WE, Piatyszek MA, Rainey WE, et al.: Telomerase activity in human germline and embryonic tissues and cells. Dev Genet 1996, 18: 173-179.
36. Bodnar A, Kim NW, Effros RB, et al.: Mechanism of telomerase induction during T cell activation. Exp Cell Res 1996, 228: 58-64.
37. Broccoli D, Young JW, de Lange T: Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci U S A 1995, 92: 9082-9086.
38. Chiu C-P, Dragowska W, Kim NW, et al.: Differential expression of telomerase activity in hematopoietic progenitors from adult human bone marrow. Stem Cells 1996, 14: 239-248.
39. Hiyama K, Hirai Y, Kyoizumi S, et al.: Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 1995, 155: 3711-3715.
40. Tahara H, Nakanishi T, Kitamoto M, et al.: Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas. Cancer Res 1995, 55: 2734-2736.
41. Taylor RS, Ramirez RD, Ogoshi M, et al.: Detection of telomerase activity in malignant and nonmalignant skin conditions. J Invest Dermatol 1996, 106: 759-765.
42. Harley CB: Telomere loss: mitotic clock or genetic time bomb? Mut Res 1991, 256: 271-282.
43. Bodnar AG, Ouellette M, Frolkis M, et al.: Extension of life-span by introduction of telomerase into normal human cells. Science 1998, 279: 349-352.
44. Hahn WC, Stewart SA, Brooks MW, et al.: Inhibition of telomerase limits the growth of human cancer cells. Nature Med 1999, 5: 1164-1170.
45. Hahn WC, Counter CM, Lundberg AS, et al.: Creation of human tumour cells with defined genetic elements. Nature 1999, 400: 464-468.
46. Vaziri H, Benchimol S: Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Curr Biol 1998, 8: 279-282.
47. Zhang X, Mar V, Harrington L, et al.: Telomere shortening and apoptosis in telomerase-inhibited human tumor cells. Genet Dev 1999, 13: 2388-2399.
48. Prowse KR, Greider CW: Developmental and tissue specific regulation of mouse telomerase and telomere length. Proc Natl Acad Sci U S A 1995, 92: 4818-4822.
49. Starling JA, Maule J, Hastie ND, et al.: Extensive telomere repeat arrays in mouse are hypervariable. Nucleic Acids Res 1990, 18: 6881-6888.
50. Wright WE, Shay JW: Telomere dynamics in cancer progression and prevention: fundamental differences in human and mouse telomere biology. Nature Med 2000, 6: 849-851.
51. Blasco MA, Lee HW, Hande MP, et al.: Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 1997, 91: 25-34.
52. Chin L, Artandi SE, Shen Q, et al.: p53 Deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell 1999, 97: 527-538.
53. Greenberg RA, Chin L, Femino A, et al.: Short dysfunctional telomeres impair tumorigenesis in the INK4a 2/3 cancer-prone mouse. Cell 1999, 97: 515-525.
54. Herrera E, Martinez-A C, Blasco MA: Impaired germinal center reaction in mice with short telomeres. EMBO J 2000, 19: 472-481.
55. Herrera E, Samper E, Martin-Caballero J, Flores, et al.: Disease states associated with telomerase deficiency appear earlier in mice with short telomeres. EMBO J 1999, 18: 2950-2960.
56. Lee H-W, Blasco MA, Gottlieb G, et al.: Essential role of mouse telomerase in highly proliferative organs. Nature 1998, 392: 569-574.
57. Rudolph KL, Chang S, Lee H-W, et al.: Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell 1999, 96: 701-712.
58. Rudolph KL, Chang S, Millard M, et al.: Inhibition of experimental liver cirrhosis in mice by telomerase gene delivery. Science 2000, 287: 1253-1258.
59. Gonzalez-Suarez, E, Samper E, Flores JM, et al.: Telomerasedeficient mice with short telomeres are resistant to skin tumorigenesis. Nature Genet 2000, 26: 1-4.
60. Artandi SE, Chang S, Lee S-L, et al.: Telomere dysfunction promotes non-reciprocal translocations and development of epithelial cancers in mice. Nature 2000, 406: 641-645.
61. Beckman KB, Ames BN: The free radical theory of aging matures. Physiol Rev 1998, 78: 547-581.
62. Barja G: Mitochonderial free radical production and aging in mammals and birds. Ann N Y Acad Sci 1998, 854: 224-238.
63. Allen RG, Tresini M: Oxidative stress and gene regulation. Free Rad Biol Med 2000, 28: 463-499.
64. Berk BC: Redox signals that regulate the vascular response to injury. Thromb Haemost 1999, 82: 810-817.
65. Lu S: Regulation of glutathione synthesis. Curr Top Cel Regul 2000, 26: 95-116.
66. Halliwell B, Gutteridge JM: Free Radicals in Biology and Medicine. Oxford: Oxford University Press; 1989.
67. Pearl R: The Rate of Living. London: University of London Press; 1928.
68. Sohl RS: Metabolic rate and life span. In Cellular Aging: Concepts and Mechanisms. Edited by Witler R. Basel, Switzerland: Karger; 1976: 25-40.
69. Ames BN, Gold LS, Willet WC: The causes and prevention of cancer. Proc Natl Acad Sci U S A 1995, 92: 5258-5265.
70. Griendling KK, Sorescu D, Ushio-Fukai M: NAD(P)H oxidase role in cardiovascular biology and disease. Circ Res 2000, 86: 494-501.
71. Smith MA, Sayre LM, Monnier VM, et al.: Radical ageing in Alzheimer's disease. Trends Neurosci 1995, 18: 172-176.
72. Dean RT, Fu S, Stocker R, et al.: Biochemistry and pathobiology of radical-mediated protein oxidation. Biochem J 1997, 324: 1-18.
73. Stein GH, Drulinger LF, Soulard A, et al.: Differential roles of cyclin-dependent kinase inhibitors P21 and P16 in the mechanisms of senescence and differentiation in human fibroblasts. Mol Cell Biol 1999, 19: 2109-2117.
74. Vaziri H, West MD, Alsopp RC, et al.: ATM-dependent telomere loss in aging human diploid fibroblasts and DNA damage lead to the post-translateral activation of p53 protein involving poly (AR-ribose) polymerase. EMBO J 1997, 16: 6018-6033.
75. Sitte N, Saretzki G, von Zglinicki T: Accelerated telomere shortening in fibroblasts after extended periods of confluency. Free Radic Biol Med 1998, 24: 885-893.
76. von Zglinicki T: Role of oxidative stress in telomere length regulation and replicative senescence. Ann N Y Acad Sci 2000, 908: 99-110.
77. Swei A, Lacy F, DeLano FA, et al.: Oxidative stress in the Dahl hypertensive rat. Hypertension 1997, 30: 1628-1633.
78. Suzuki H, DeLano FA, Parks DA, et al.: Xanthine oxidase activity associated with arterial blood pressure in spontaneously hypertensive rats. Proc Natl Acad Sci U S A 1998, 95: 4754-4759.
79. Suzuki H, Swei A, Zweifach BW, et al.: In vivo evidence for microvascular oxidative stress in spontaneously hypertensive rats: hydroethidine microfluorography. Hypertension 1995, 25: 1083-1089.
80. Vaziri ND, Oveisi F, Ding Y: Role of increased free radical activity in the pathogenesis of uremic hypertension. Kidney Int 1998, 53: 1748-1754.
81. Vaziri ND, Liang K, Ding Y: Increased nitgric oxide inactivation by reactive oxygen species in lead-induced hypertension. Kidney Int 1998, 53: 1748-1754.
82. Lopez-Ongil S, Hernandez-Perera O, Navarro-Antolin J, et al.: Role of reactive oxygen species in the signaling cascade of cyclosporine A-mediated up-regulation of eNOS in vascular endothelial cells. Br J Pharmacol 1998, 124: 447-454.
83. Vaziri ND, Wang XQ, Oveisi F, et al.: Induction of oxidative stress by glutathione depletion causes severe hypertension in normal rats. Hypertension 2000, 36: 142-146.
84. Lacy F, O'Connor DT, Schmid-Schonbein GW: Plasma hydrogen peroxide production in hypertensives and normotensive subjects at genetic risk of hypertension. J Hypertens 1998, 16: 291-303.
85. Lacy F, Kailasam MT, O'Connor DT, et al.: Plasma hydrogen peroxide production in human essential hypertension. Role of heredity, gender, and ethnicity. Hypertension 2000, 36: 878-884.
86. Bolzan AD, Bianchi MS, Bianchi NO: Superoxide dismutase, catalase and glutathione peroxidase activities in human blood: influence of sex, age and cigarette smoking. Clin Biochem 1997, 30: 449-454.
87. Tang M, Subbiah MT: Estrogens protect against hydrogen peroxide and arachidonic acid induced DNA damage. Biochem Biophys Acta 1996, 1299: 155-159.
88. Romer W, Oettel M, Menzenbach B, et al.: Novel estrogens and their radical scavenging effects, iron-chelating and total antioxidative activities: 17 alpha-substituted analogs of delta 9 (11)-dehydro-17 beta estradiol. Steroids 1997, 62: 688-694.
89. Okuda K, Khan MY, Skurnick J, et al.: Telomere attrition of the human abdominal aorta: relationships with age and atherosclerosis. Atherosclerosis 2000, 152: 391-398.
90. Xu D, Neville R, Finkel T: Homocysteine accelerates endothelial cell senescence. FEBS Lett 2000, 470: 20-24.
91. O'Rourke M, Frohlich ED: Pulse pressure: is this a clinically useful risk factor? Hypertension 1999, 34: 372-374.
92. Izzo JL Jr, Levy D, Black HR: Clinical Advisory Statement. Importance of systolic blood pressure in older Americans. Hypertension 2000, 35: 1021-1024.
93. Zhang Y, Stewart KG, Dandge ST: Estrogen replacement reduces age-associated remodeling in rat mesenteric arteries. Hypertension 2000, 36: 970-974.
94. Jeanclos E, Schork NJ, Kyvik KO, et al.: Telomere length inversely correlates with pulse pressure and is highly familial. Hypertension 2000, 36: 195-200.
95. Benetos A, Okuda K, Lajemi M, et al.: Telomere length as an indicator of biological aging: the gender effect and relation with pulse pressure and pulse wave velocity. Hypertension 2001, in press.
96. von Zglinicki T, Serra V, Lorenz M, et al.: Short telomeres in patients with vascular dementia: an indicator of low antioxidative capacity and possible risk factor? Lab Invest 2000, 80: 1739-1747.
97. Slagboom PE, Droog S, Boomsma DI: Genetic determination of telomere size in humans: a twin study of three age groups. Am J Hum Genet 1994, 55: 876-882.
98. Kyo S, Takakura M, Kanaya T, et al.: Estrogen activates telomerase. Cancer Res 1999, 59: 5917-5921.
99. O'Brien W, Stenman G, Sager R: Suppression of tumor growth by senescence in virally transformed human fibroblasts. Proc Natl Acad Sci U S A 1986, 83: 8659-8663.